Long-Term Effectiveness of Natalizumab in Patients with Relapsing-Remitting Multiple Sclerosis Treated in the Routine Care in Greece: Results from the Multicenter, Observational 5-Year Prospective Study ‘TOPICS Greece’

BACKGROUND AND OBJECTIVES: For chronic diseases like multiple sclerosis (MS), real-world evidence on long-term treatment outcomes is essential. The study aimed to provide long-term data on the safety and effectiveness of natalizumab in patients with relapsing-remitting MS (RRMS) treated in a routine...

Descripción completa

Detalles Bibliográficos
Autores principales: Efthimios, Dardiotis, Georgios, Karachalios, Antonia, Alexopoulou, Rania, Gourgioti, Maria-Eleutheria, Evangelopoulos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481212/
https://www.ncbi.nlm.nih.gov/pubmed/34427893
http://dx.doi.org/10.1007/s40261-021-01073-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481212/
https://www.ncbi.nlm.nih.gov/pubmed/34427893
http://dx.doi.org/10.1007/s40261-021-01073-y

Ejemplares similares